AutoShip makes it easier to keep your pet's medications on hand!
Convenience: We contact your vet when it’s time to renew your pet’s prescription.
Reminders: You’ll receive reminders prior to shipping, so you’ll have time to make changes.
Savings: Save on the initial order PLUS 5% on future deliveries.
Flexibility: Easily change, skip, or cancel anytime on your My AutoShip page.
Support: Our customer service team is here to help with any questions or concerns.
1 of 1
Click on image to open expanded view
Item No.
53247
You may also like
One-time purchase
$12.99
Product Description
Numelvi is indicated for the control of pruritus associated with allergic dermatitis in dogs 6 months of age and older.
Who is Numelvi (atinvicitinib tablets) for Dogs for?
Dogs (6 months of age or older)
Why use Numelvi (atinvicitinib tablets) for Dogs?
Numelvi (atinvicitinib tablets) is The Future of Itch Relief! The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for Dogs.
How does Numelvi (atinvicitinib tablets) for Dogs work?
- At least 10X more selective for JAK11*
- Starts reducing itch within 2-4 hours2†
->82% of dogs showed significant‡
improvement in itch within 1 week 3
- Approved for dogs and puppies as young
as 6 months of age and can be used in
dogs weighing at least 2 kg
- Proven safety for dogs
- Once-daily dosing from day 1§
*Over the other JAK enzymes in in vitro assays.
† In a canine interleukin-31 (cIL-31)-induced pruritus model.
‡ A =2 cm reduction in owner Pruritus Visual Analog Scale.
§ Numelvi is taken at or around mealtime
Manufacturer:
Merck Animal Health
Active Ingredients(s):
Atinvicitinib
How is Numelvi (atinvicitinib tablets) for Dogs sold?
Sold as tablets in strengths of 4.8 mg, 7.2 mg, 21.6 mg or 31.6 mg in counts of 1, 30 or 90.
What are the side effects of Numelvi (atinvicitinib tablets) for Dogs?
ADVERSE REACTIONS:
In a masked field study assessing effectiveness and safety of Numelvi for the control of pruritus associated with allergic dermatitis in dogs, 144 Numelvi-treated dogs and 144 placebo-treated dogs were evaluated for safety for up to 28 days. Adverse reactions seen during the field study are summarized in Table 1 on the label.
What special precautions are there?
User Safety Warnings: This product is not for human use. Keep this and all drugs out of reach of children. Wash hands thoroughly with soap and water immediately after handling tablets. In case of accidental ingestion, seek medical attention immediately.
Animal Safety Warnings:
Dogs should be monitored for the development of infections because NUMELVI may increase susceptibility to opportunistic infections, including demodicosis and interdigital furunculosis (see Target Animal Safety).
Numelvi is not for use in dogs with serious infections.
Numelvi is a JAK inhibitor. New neoplastic conditions (benign and malignant) have been reported in dogs treated with other JAK inhibitors. Consider the risks and benefits of treatment prior to initiating NUMELVI in dogs with a history of recurrent demodicosis.
Numelvi modulates the immune system.
Numelvi is not for use in dogs less than 6 months of age (see Target Animal Safety).
Keep Numelvi in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose.
PRECAUTIONS: The effectiveness and safety of Numelvi have not been evaluated in a field study beyond 28 days (see Adverse Reactions and Effectiveness). The safe use of Numelvi has not been evaluated in breeding, pregnant, or lactating dogs. Decreased mean testes weight was observed in a laboratory safety study (see Target Animal Safety). The safe use of Numelvi has not been evaluated in combination with glucocorticoids, cyclosporine, or other systemic immunosuppressive agents.
What to do if overdose?
Contact your nearest emergency animal hospital. For technical information or to report a suspected adverse event, please contact Merck Animal Health at 1-800-224-5318 or https://www.merck-animal-health-usa.com. Safety Data Sheets (SDSs) can be found at https://www.merck.com/products/safety-data-sheets/#.
For additional information about reporting adverse drug experiences for animal drugs, contact FDA at 1-888-FDA-VETS or https://www.fda.gov/reportanimalae.
How can I store Numelvi (atinvicitinib tablets) for Dogs?
Store at room temperature between 59-86 degrees F
Overview
Use as directed by your Veterinarian.
Numelvi should be administered orally, once daily, at a dose of 0.36 to 0.54 mg atinvicitinib/lb (0.8 to 1.2 mg atinvicitinib/kg) body weight according to the Dosing Table. NUMELVI should be administered with food.
Main Ingredients
Active Ingredient: Atinvicitinib